Globus Medical (GMED) Misses Q1 EPS by 5c, Confirms Guidance

Globus Medical (NYSE: GMED) reported Q1 EPS of $0.36, $0.05 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $182.9 million versus the consensus estimate of $186.59 million.

GUIDANCE:

Globus Medical sees FY2019 EPS of $1.72, versus the consensus of $1.72. Globus Medical sees FY2019 revenue of $770 million, versus the consensus of $770.8 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Evogene (EVGN) Tops Q2 EPS by 15c
• Home Depot beats estimates, reaffirms fiscal 2026 guidance